Stock Analiz

Fresenius Medical Care AG (FMS) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Fresenius Medical Care’s revenue went from $17.9B in fiscal 2016 to $23.1B in fiscal 2025, growth of about 2.8% a year.

Net income in fiscal 2025 was $1.1B, a net margin of 5.0%; the best year in this period was 2018 with $2.3B.

Over the twelve months to September 30, 2026, revenue was $21.5B and net income $907M.

Revenue, profit and cash flow by year

Revenue
2016: $17.9B162017: $21.3B172018: $18.9B182019: $19.6B192020: $21.9B202021: $20.0B212022: $20.7B222023: $21.5B232024: $20.1B242025: $23.1B25$23.1B
Net income
2016: $1.2B162017: $1.5B172018: $2.3B182019: $1.3B192020: $1.4B202021: $1.1B212022: $718M222023: $551M232024: $559M242025: $1.1B25$1.1B
Free cash flow
2016: $1.1B20162017: $1.5B20172018: $1.2B20182019: $1.6B2019$1.6B
EPS (diluted)
2016: $2.23162017: $2.75172018: $4.06182019: $2.41192020: $2.56202021: $1.97212022: $1.29222023: $0.99232024: $1.00242025: $2.0625$2.06

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$21.5B$23.1B$20.1B$21.5B$20.7B$20.0B$21.9B$19.6B$18.9B$21.3B$17.9B
Gross profit—$5.9B$4.9B$5.4B$5.7B$5.8B$6.8B$6.1B$5.9B$7.2B$5.8B
Operating income—$2.1B$1.4B$1.5B$1.6B$2.1B$2.8B$2.5B$3.5B$2.8B$2.6B
Net income$907M$1.1B$559M$551M$718M$1.1B$1.4B$1.3B$2.3B$1.5B$1.2B
EPS (diluted)$1.66$2.06$1.00$0.99$1.29$1.97$2.56$2.41$4.06$2.75$2.23
R&D——————————$162M
Revenue growth—+14.8%−6.6%+3.9%+3.7%−8.9%+11.6%+3.6%−11.2%+19.1%+6.5%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$3.2B$3.2B$2.5B$2.9B$2.3B$2.8B$5.2B$2.9B$2.4B$2.6B$2.1B
Capital spending-$1.2B——————-$1.3B-$1.2B-$1.1B-$1.0B
Free cash flow$2.0B——————$1.6B$1.2B$1.5B$1.1B
Dividends paid$441M$496M$363M$363M$422M$444M$431M$398M$372M$353M$277M
Buybacks—$688M————$449M$674M$43M$69M$0
Stock-based pay———————$2M$12M$56M$26M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$1.9B$1.2B$1.6B$1.4B$1.7B$1.3B$1.1B$2.6B$1.2B$747M
Debt—$12.7B$11.4B$13.5B$14.1B$15.1B$15.2B$15.5B$8.6B$8.0B$8.0B
Equity—$15.6B$15.1B$15.1B$14.9B$14.4B$13.8B$13.4B$13.5B$11.8B$10.8B
Total assets—$36.4B$34.9B$37.5B$38.1B$38.9B$38.9B$37.0B$30.0B$28.8B$26.9B
Shares (diluted)546M559M559M559M559M559M559M559M559M559M559M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin—25.6%24.6%25.3%27.4%28.8%31.0%30.9%31.1%33.8%32.3%
Operating margin—9.3%7.2%7.0%7.8%10.5%12.9%13.0%18.4%13.3%14.7%
Net margin4.2%5.0%2.8%2.6%3.5%5.5%6.5%6.9%12.0%7.2%6.9%
FCF margin9.2%——————8.2%6.1%7.0%6.2%
ROIC—6.0%3.8%3.8%4.1%5.5%7.2%6.9%12.8%11.1%9.8%
ROE—7.3%3.7%3.7%4.8%7.6%10.4%10.0%16.9%13.0%11.5%

Frequently asked questions

What is Fresenius Medical Care’s annual revenue?

$23.1B in fiscal 2025 and $21.5B over the twelve months to September 30, 2026.

How much profit does Fresenius Medical Care make?

Net income was $1.1B in fiscal 2025 (net margin 5.0%).

Is Fresenius Medical Care’s revenue growing?

Yes: revenue rose 14.8% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.